장내세균에서 β-lactam 항균제의 내성기전별 항균제 감수성검사의 해석
Interpretation of Antimicrobial Susceptibility Test According to Resistance Mechanism of β-lactam in Enterobacteriacae
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
It is important to select appropriate antimicrobials for the treatment of infection according to the results of antimicrobial susceptibility tests (ASTs), yet the clinical isolates are sometimes susceptible to antibiotics that are clinically ineffective or this is due to technical error of the ASTs. So, interpretive reading of ASTs is needed and especially for the β-lactams for treating Enterobacteriacae. This review describes the interpretive reading of ASTs according to natural antimicrobial resistance and the mechanisms of mechanisms, with giving special attention to the antibiotics phenotypes for Enterobacteriacae. Further, as all the diffent tissues have a different antimicrobial concentration for identical antimicrobials, more information is needed on the antimicrobial tissue distribution for the appropriate treatment of infection. (ED note: I hope you send me the paper.)
Abstract
It is important to select appropriate antimicrobials for the treatment of infection according to the results of antimicrobial susceptibility tests (ASTs), yet the clinical isolates are sometimes susceptible to antibiotics that are clinically ineffective or this is due to technical error of the ASTs. So, interpretive reading of ASTs is needed and especially for the β-lactams for treating Enterobacteriacae. This review describes the interpretive reading of ASTs according to natural antimicrobial resistance and the mechanisms of mechanisms, with giving special attention to the antibiotics phenotypes for Enterobacteriacae. Further, as all the diffent tissues have a different antimicrobial concentration for identical antimicrobials, more information is needed on the antimicrobial tissue distribution for the appropriate treatment of infection. (ED note: I hope you send me the paper.)
참고문헌 (26)
- Brun-Buisson C, "Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae", Lancet, 2(8554), pp.302~306 (1987)
- Courvalin P, "Interpretive reading of in vitro antibiotic susceptibility tests(the antibiogramme)", Clin Microbiol Infect, 2(Suppl. 1), pp.26~34 (1996)
- 어영, "Antibiogram을이용한 디스크 감수성 검사 결과의 판독과 정도관리 프로그램의 개발", 대한임상병리학회지, 18(2), pp.168~173 (1998)
- Livermore DM, "β-lactamases in laboratory and clinical resistance", Clin Microbiol Rev, 8(4), pp.557~584 (1995)
- Vedel G, "Evaluation of an expert system linked to a rapid antibiotic susceptibility testing system for the detection of β-lactam resistance phenotypes", Res Microbiol, 147(4), pp.297~309 (1996)
- Jorgensen JH, "Manual for clinical microbiology", pp.1108~1127 (2003), American Society for Microbiology
- Andrews JM, "The development of the BSAC standardized method of disc diffusion testing", J Antimicrob Chemother, 48(Suppl. 1), pp.29~42 (2001)
- Performance Standards for antimicrobial susceptibility testing, "Clinical and laboratory standards institute", Clinical and laboratory standards institute, ~, pp.Twentieth Information supplement, M100-S20 (2010)
- Rice LB, "Manual for clinical microbiology", pp.1074~1101 (2003), American Society for Microbiology
- Livermore DM, "β-lactamase-mediated resistance and opportunities for its control", J Antimicrob Chemther, 41(Suppl. D), pp.25~41 (1998)
- Livermore DM, "Antibiotics in laboratory medicine", pp.502~578 (1996), Williams & Wilkins
- Livermore DM, "Interpretative reading: recognizing the unsual and inferring resistance mechanisms from resistance phenotypes", J Antimicrob Chemother, 48(Suppl. 1), pp.87~102 (2001)
- Moritz VA, "Cefoxitin sensitivity as a marker for inducible beta-lactamase", J Med Microbiol, 21(3), pp.203~207 (1986)
- Yang YJ, "Chromosomal β-lactamase expression and resistance to β-lactam antibiotics in Proteus vulgaris and Morganella morganii", Antimicrob Agents Chemother, 32(9), pp.1385~1391 (1988)
- Liu PY, "Survey of the prevalence of β-lactamase amongst 1000 Gram-negative bacilli, isolated consecutively at the Royal London Hospital", J Antimicrob Chemother, 30(4), pp.429~447 (1992)
- Sanders CC, "β-lactam resistance in gram-negative bacteria: global trends and clinical impact", Clin Infect Dis, 15(2), pp.824~839 (1992)
- Neu HC, "What do β-lactamases mean for clinical efficacy?", Infection, 11(Suppl. 2), pp.74~80 (1983)
- Williams JD, "The correlation of in-vitro susceptibility tests with in-vivo results of antibiotics treatment", Scand J Infect Dis Suppl, 13, pp.64~66 (1978)
- Wu PJ, "Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics", Antimicrob Agents Chemother, 38(3), pp.494~498 (1994)
- Coudron PE, "Occurrence and detection of AmpC betalactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center", J Clin Microbiol, 38(5), pp.1791~1796 (2000)
- Acar JF, "Susceptibility survey of piperacillin alone and in the presence of tazobactam", J Antimicrob Chemother, 31(Suppl. A), pp.23~28 (1993)
- Fu KP, "Piperacillin, a new penicillin active against many bacteria resistant to other penicillins", Antimicrob Agents Chemother, 13(3), pp.358~367 (1978)
- Livermore DM, "Clinical significance of β-lactamase induction and stable derepression in Gram-negative rods", Eur J Clin Microbiol, 6(4), pp.439~445 (1987)
- Yang YJ, "Chromosomal β-lactamase expression and antibiotics resistance in Enterobacter cloacae", J Med Microbiol, 25(3), pp.227~233 (1988)
- Jacoby GA, "Activities of β-lactam antibiotics against E. coli strains producing extended spectrum β-lactamases", Antimicrob Agents Chemother, 34(5), pp.858~862 (1990)
- Yang YJ, "Interactions of meropenem with class I β-lactamases", J Antimicrob Chemother, 24(Suppl A), pp.207~217 (1989)